Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,765.00p
   
  • Change Today:
    -22.00p
  • 52 Week High: 2,902.00
  • 52 Week Low: 1,637.00
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 74,268
  • Market Cap: £1,165.46m
  • RiskGrade: 128

Genus FY profits slip as weak Chinese PIC performance weighs

By Iain Gilbert

Date: Thursday 24 Feb 2022

LONDON (ShareCast) - (Sharecast News) - Biotechnology company Genus said on Thursday that full-year profits had slipped in 2021 as the group's performance was impacted by the performance of its PIC unit in China.
Genus said operating profits, including those from joint ventures, fell 19% to £35.0m, while pre-tax profits slipped 21% year-on-year to £37.0m as "challenging market conditions" for PIC in China led to a 2% slip in annual revenues to £281.2m.

The FTSE 250-listed firm noted that when excluding PIC China, group adjusted pre-tax profits were up 25% in constant currency and revenues were up 4%.

However, statutory pre-tax profits decreased 35% to £24.4m due to lower adjusted profits and a decrease in the net valuation of its IAS 41 biological asset.

Separately, Genus revealed that its PIC subsidiary has entered into definitive agreements with Canadian agrifood business Olymel for the provision of genetic products and services in connection with its AlphaGene porcine genetic improvement program.

Genus said the collaboration with Olymel increases PIC's footprint in the Canadian porcine genetics market and will better allow both parties to serve pork producers across the country.

As of 0940 GMT, Genus shares were down 5.76% at 2,980.0p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 1,765.00p
Change Today -22.00p
% Change -1.23 %
52 Week High 2,902.00
52 Week Low 1,637.00
Volume 74,268
Shares Issued 66.03m
Market Cap £1,165.46m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
96.03% below the market average96.03% below the market average96.03% below the market average96.03% below the market average96.03% below the market average
96.3% below the sector average96.3% below the sector average96.3% below the sector average96.3% below the sector average96.3% below the sector average
Price Trend
55.89% below the market average55.89% below the market average55.89% below the market average55.89% below the market average55.89% below the market average
26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average
Income
86.13% below the market average86.13% below the market average86.13% below the market average86.13% below the market average86.13% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
70.66% below the market average70.66% below the market average70.66% below the market average70.66% below the market average70.66% below the market average
72.97% below the sector average72.97% below the sector average72.97% below the sector average72.97% below the sector average72.97% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 29-Feb-24 09-Nov-23
Paid 28-Mar-24 08-Dec-23
Amount 10.30p 21.70p

Trades for 28-Mar-2024

Time Volume / Share Price
16:58 36 @ 1,785.75p
16:35 42,488 @ 1,765.00p
16:35 110 @ 1,765.00p
16:35 598 @ 1,765.00p
16:35 114 @ 1,765.00p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page